Transtympanic iontophoresis of gadopentetate dimeglumine: Preliminary results

Otolaryngology - Head and Neck Surgery

Volumn 129, Issue 4, 2003, Pages 408-413

  Christodoulou, Panagiotis ^a   Doxas, Panagiotis G ^a   Papadakis, Chariton E ^a   Prassopoulos, Panos ^a   Maris, Thomas ^a   Helidonis, Emmanuel S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIINFLAMMATORY AGENT; BENZYDAMINE; CONTRAST MEDIUM; CORTICOSTEROID; DEXAMETHASONE; FERROMAGNETIC MATERIAL; GADOLINIUM PENTETATE MEGLUMINE; HYDROCORTISONE; METHYLPREDNISOLONE; MUCOLYTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EARDRUM; INNER EAR DISEASE; IONTOPHORESIS; MIDDLE EAR DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PERILYMPH; RABBIT; SAFETY; SEMICIRCULAR CANAL;

EID: 0141958150     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0194-5998(03)00713-7     Document Type: Article

References (20)

1. Passali D, Bellussi L, Masieri S. Transtympanic iontophoresis: personal experience. Laryngoscope 1984;94: 802-6.
2. Sato H, Takahashi H, Honjo I. Transtympanic iontophoresis of dexamethasone and fosfomycin. Arch Otolaryngol Head Neck Surg 1988;114:531-3.
3. Gillespie CA, Swanson GC, Johnson CM, et al. Inner ear lidocaine concentration following iontophoresis. Laryngoscope 1980;90:1845-51.
4. Shulman A. Medical methods, drug therapy, and tinnitus control strategies. In: Shulman A, Aran JM, Tonndorf J, et al, editors. Tinnitus, Diagnosis/treatment. San Diego (CA): Singular Publishing; 1997. p. 453-89.
5. Brusis T, Loennecken I. Treatment of tinnitus with iontophoresis and local anesthesia. Laryngol Rhinol Otol (Stuttg) 1985;64:355-8.
6. Laffrée JB, Vermeij P, Hulshof JH. The effect of iontophoresis of lignocaine in the treatment of tinnitus. Clin Otolaryngol 1989;14:401-4.
7. Willat DJ. A sequential double-blind crossover trial of iontophoresis. In: Feldmann H, Third International Tinnitus Seminar 1987. Karlsruhe, Proceedings, Germany: Verlag; 1987. p. 316-9.
8. Licht S. History of electrotherapy. In: Stillwell GK, editor. Therapeutic electricity and ultraviolet radiation. Baltimore (MD): Williams & Williams; 1983. p. 8-21.
9. Chien YW, Banga AK. Iontophoretic (transdermal) delivery of drugs: overview of historical development. J Pharm Sci 1989;78:353-4.
10. LeDuc S. Electric ions and their uses in medicine. London: Rebman; 1908. p. 87.
11. Gangarosa LP, Park NH, Wiggins CA, et al. Increased penetration of nonelectrolytes into mouse skin during iontophoretic water transport (iontohydrokinesis). J Pharmacol Exp Ther 1980;212:377-81.
12. Chien YW, Siddiqui O, Shi WM, et al. Direct current iontophoretic transdermal delivery of peptide and protein drugs. J Pharm Sci 1989;78:376-83.
13. Schuknecht HF. Ablation therapy in the management of Méniè re's disease. Acta Otolaryngol (Stockh) 1957;132: 3-42.
14. Magnusson M, Padoan S. Delayed onset of ototoxic effects of gentamicin in treatment of Ménière's disease. Rationale for extremely low dose therapy. Acta Otolaryngol (Stockh) 1991;111:671-6.
15. Driscoll CL, Kasperbauer JL, Facer GW, et al. Low-dose intratympanic gentamicin and the treatment of Ménière's disease: preliminary results. Laryngoscope 1997;107: 83-9.
16. Kaasinen S, Pyykko I, Ishizaki H, et al. Intratympanic gentamicin in Ménière's disease. Acta Otolaryngol (Stockh) 1998;118:294-8.
17. McFeely WJ, Singleton GT, Rodriguez FJ, et al. Intratympanic gentamicin treatment for Ménière's disease. Otolaryngol Head Neck Surg 1998;118:589-96.
18. Blakley BW. Update on intratympanic gentamicin for Méniè re's disease. Laryngoscope 2000;110:236-40.
19. Silverstein H, Isaacson JE, Olds MJ, et al. Dexamethasone inner ear perfusion for the treatment of Ménière's disease: a prospective, randomized, double-blind, crossover trial. Am J Otol 1998;19:196-201.
20. Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999; 109(Suppl 91):1-17.